id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2005-N-0230-0005,FDA,FDA-2005-N-0230,SUPPORTING STATEMENT,Supporting & Related Material,Background Material,2006-06-16T04:00:00Z,2006,6,,,2025-07-17T01:44:52Z,,0,0,090000648044216e
FDA-2005-N-0230-0006,FDA,FDA-2005-N-0230,SUPPORTING STATEMENT,Supporting & Related Material,Background Material,2006-06-16T04:00:00Z,2006,6,,,2025-07-17T01:45:01Z,,0,0,090000648044216f
FDA-2005-N-0230-0007,FDA,FDA-2005-N-0230,Agency Information Collection Activities; Proposed Collection; Comment Request; Evaluation of Consumer-Friendly Formats for Brief Summary in Direct-to-Consumer Print Advertisements for Prescription Drugs: Study 1,Notice,Notice of Approval,2006-06-16T04:00:00Z,2006,6,2006-06-08T04:00:00Z,,2025-09-16T20:46:46Z,E6-8981,0,0,0900006480442170